S-3 S1 Summary of GC/MS analysis identified metabolites in serum samples from STEMI patients, UA patients and healthy controls. S-11 S2 Summary of 1 H-NMR analysis identified metabolites in serum samples from STEMI patients, UA patients and healthy controls.
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Supplementary Figure   Description S-6 S1 GC/MS based OPLS-DA of STEMI patients ( ) versus healthy controls ( ) after removing major peaks revealed from the first OPLS analysis. S-7 S2 GC/MS based PCA of the fatty acids profile of STEMI patients ( ), before stent samples of unstable angina patients ( ) and healthy controls ( ). S-8 S3 GC/MS based OPLS-DA of the fatty acids profile of STEMI patients ( ), before stent samples of unstable angina patients ( ) and healthy controls ( ). S-9 S4 SPME-GC/MS of a healthy control ( ) and a STEMI patient ( ). S-10 S5 A 600 MHz 1 H-NMR spectrum of a healthy human serum with expanded spectral region (B and C). Table S1 ).
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Figure S5
A 600 MHz 1 H-NMR spectrum of a healthy human serum with expanded spectral region (B and C). 
